Perpetua Medical ABOMXSTO: PERP_B

PERP_B: Strong sales growth from ES-Medical offset by negative operating result and strategic realignment

· Issued by Perpetua Medical AB

Net sales rose 135% year-over-year to 3,227 KSEK, driven by the ES-Medical acquisition, but operating profit turned negative due to one-off costs and business transitions. Acquisition strategy remains unchanged, with ongoing efforts to divest Wastelog.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Perpetua Medical AB on 6ix

Earlier from Perpetua Medical

Later from Perpetua Medical

All Perpetua Medical news releases